Literature DB >> 22635209

When APS (Hughes syndrome) met the autoimmune/inflammatory syndrome induced by adjuvants (ASIA).

M Blank1, E Israeli, Y Shoenfeld.   

Abstract

Vaccination of healthy individuals is the most effective approach to protect the public from infections and prevent the spread of many infectious diseases all over the globe. Licensed vaccines are mostly safe, but in rare cases they may be associated with humoral response to self-antigens due to molecular mimicry, epitope spread, bystander activation or polyclonal triggering. Moreover, the clinical picture of autoimmune conditions following post-vaccination is rarer. Nevertheless, anecdotal case reports on the flare of autoimmune response with clinical manifestations were reported. Herein, we discuss this topic in relation to post-vaccination-induced antiphospholipid antibodies following tetanus toxoid vaccine, HBV and influenza associated in rare cases with antiphospholipid syndrome clinical manifestations. We will discuss the possible mechanisms which pertain to ASIA (Shoenfeld syndrome).

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22635209     DOI: 10.1177/0961203312438115

Source DB:  PubMed          Journal:  Lupus        ISSN: 0961-2033            Impact factor:   2.911


  12 in total

Review 1.  Pediatric antiphospholipid syndrome.

Authors:  Cassyanne L Aguiar; Arzu Soybilgic; Tadej Avcin; Barry L Myones
Journal:  Curr Rheumatol Rep       Date:  2015-04       Impact factor: 4.592

2.  The epidemiological profile of ASIA syndrome after HPV vaccination: an evaluation based on the Vaccine Adverse Event Reporting Systems.

Authors:  Paolo Pellegrino; Valentina Perrone; Marco Pozzi; Carla Carnovale; Cristiana Perrotta; Emilio Clementi; Sonia Radice
Journal:  Immunol Res       Date:  2015-02       Impact factor: 2.829

Review 3.  When uncommon and common coalesce: adult onset Still's disease associated with breast augmentation as part of autoimmune syndrome induced by adjuvants (ASIA).

Authors:  A Dagan; M Kogan; Y Shoenfeld; G Segal
Journal:  Clin Rheumatol       Date:  2015-01-22       Impact factor: 2.980

Review 4.  Vaccine-preventable infections in Systemic Lupus Erythematosus.

Authors:  Giuseppe Murdaca; Andrea Orsi; Francesca Spanò; Valeria Faccio; Francesco Puppo; Paolo Durando; Giancarlo Icardi; Filippo Ansaldi
Journal:  Hum Vaccin Immunother       Date:  2016-03-03       Impact factor: 3.452

5.  Effects of adjuvants for human use in systemic lupus erythematosus (SLE)-prone (New Zealand black/New Zealand white) F1 mice.

Authors:  E Favoino; E I Favia; L Digiglio; V Racanelli; Y Shoenfeld; F Perosa
Journal:  Clin Exp Immunol       Date:  2014-01       Impact factor: 4.330

6.  Pancreatitis after human papillomavirus vaccination: a matter of molecular mimicry.

Authors:  Mojca Bizjak; Or Bruck; Sonja Praprotnik; Shani Dahan; Yehuda Shoenfeld
Journal:  Immunol Res       Date:  2017-02       Impact factor: 2.829

7.  A sudden onset of a pseudo-neurological syndrome after HPV-16/18 AS04-adjuvated vaccine: might it be an autoimmune/inflammatory syndrome induced by adjuvants (ASIA) presenting as a somatoform disorder?

Authors:  Dimitri Poddighe; Lucia Castelli; Gian Luigi Marseglia; Paola Bruni
Journal:  Immunol Res       Date:  2014-12       Impact factor: 4.505

Review 8.  Environmental Triggers of Autoreactive Responses: Induction of Antiphospholipid Antibody Formation.

Authors:  Anush Martirosyan; Rustam Aminov; Gayane Manukyan
Journal:  Front Immunol       Date:  2019-07-10       Impact factor: 7.561

Review 9.  Vaccines, adjuvants and autoimmunity.

Authors:  Luísa Eça Guimarães; Britain Baker; Carlo Perricone; Yehuda Shoenfeld
Journal:  Pharmacol Res       Date:  2015-08-12       Impact factor: 7.658

10.  Isolated IgA anti- β2 glycoprotein I antibodies in patients with clinical criteria for antiphospholipid syndrome.

Authors:  Raquel Ruiz-García; Manuel Serrano; José Ángel Martínez-Flores; Sergio Mora; Luis Morillas; María Ángeles Martín-Mola; José M Morales; Estela Paz-Artal; Antonio Serrano
Journal:  J Immunol Res       Date:  2014-03-23       Impact factor: 4.818

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.